|
1 Indications And Usage Viramune Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus (Hiv-1) Infection In Adults And Pediatric Patients 15 Days And Older [See Clinical Studies (14.1 , 14.2) ] . Limitations Of Use: Based On Serious And Life-Threatening Hepatotoxicity Observed In Controlled And Uncontrolled Trials, Viramune Is Not Recommended To Be Initiated, Unless The Benefit Outweighs The Risk, In: Adult Females With Cd4 + Cell Counts Greater Than 250 Cells/mm 3 Or Adult Males With Cd4 + Cell Counts Greater Than 400 Cells/mm 3 [See Warnings And Precautions ( 5.1 )] . Viramune Is An Nnrti Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus (Hiv-1) Infection In Adults And Pediatric Patients 15 Days And Older. (1) Limitations Of Use: Based On Serious And Life-Threatening Hepatotoxicity Observed In Controlled And Uncontrolled Trials, Viramune Is Not Recommended To Be Initiated, Unless The Benefit Outweighs The Risk, In: Adult Females With Cd4 + Cell Counts Greater Than 250 Cells/mm 3 Adult Males With Cd4 + Cell Counts Greater Than 400 Cells/mm 3 (1 , 5.1)
|